The Intramural Research Program (IRP), National Institute on Drug Abuse (NIDA), a research component of the National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is seeking an outstanding Physician to provide branch-wide clinical research medical oversight and coordination of the extensive support resources required for the sound conduct of the clinical research protocols within NIDA. The selected candidate will also work closely with the Senior Investigator to conduct cutting-edge translational and clinical research related to addiction, neuroscience and mental health.
We are seeking a candidate who is committed to both patient safety and scientific excellence and understands the intellectual benefits of collaborative research to enhance emerging areas of human based research. The Physician will provide patient care and clinical support to study participants (e.g. healthy volunteers, individuals with alcohol and substance use disorders) for outpatient and inpatient human research studies. The selected candidate will also be heavily involved in the scientific and research program of the branch investigators, e.g. development of novel translational and clinical research, design of clinical protocols, dissemination of research findings at conferences and lectures and publication of the results in peer-reviewed Journals.
The selected candidate will serve as a scientist and as the study physician on a variety of research protocols related to substance use and addiction. The ideal candidate will contribute to a multidisciplinary team investigating novel diagnostic and treatment approaches for addiction. NIDA will provide clinical and office space adequate to assist in carrying out the job duties at the Biomedical Research Center, located on the Johns Hopkins Bayview Campus in Baltimore, MD. The main NIH campus and the NIDA IRP located in Baltimore provide a rich and highly interactive translational clinical environment. Full federal benefits include retirement, health and life insurance, long-term care insurance, leave, and a Thrift Savings Plan (401k equivalent). Salary will be commensurate with experience.
Appointees must be U.S. citizens. The successful candidate must possess a M.D., D.O. or equivalent degree(s) and must have all the credentials required for licensing to allow the practice of medicine in the United States. Board certification by an appropriate American Board (for example psychiatry, internal medicine, family medicine, neurology, clinical pharmacology or other related medical specialty) is preferred. Experience in addiction is desirable.
Review of applications will begin in late September 2020 and continue until the position is filled.
For additional information, you may contact:
Lorenzo Leggio, M.D., Ph.D., Senior Investigator, NIDA, firstname.lastname@example.org
The NIH encourages the application and nomination of qualified women, minorities and individuals with disabilities.
The HHS and NIH are Equal Opportunity Employers
Internal Number: WM205721
About National Institute on Drug Abuse, Intramural Research Program
The mission of the Intramural Research Program (IRP) of the National Institute on Drug Abuse is to conduct state-of-the-art research on basic mechanisms that underlie drug abuse and addiction, and to develop new methods for the treatment of drug abuse and addiction. Research is supported at the molecular, genetic, cellular, animal, and clinical levels and is conceptually integrated, highly innovative, and focused on major problems in the field. The long-term goal of the research is to better understand the biological and behavioral factors contributing to initiation, maintenance, and elimination of drug abuse and addiction (and associated diseases), and to translate this knowledge into improved strategies for preventing, treating, and reducing the negative consequences for the individual and for society caused by drug abuse and addiction. An important aspect of the program is the training of young investigators and career development of more experienced investigators in basic and clinical sciences related to drug abuse research.